Path: ...!3.us.feeder.erje.net!2.eu.feeder.erje.net!feeder.erje.net!news2.arglkargh.de!news.mixmin.net!proxad.net!feeder1-2.proxad.net!usenet-fr.net!pasdenom.info!from-devjntp
Message-ID: <nURdbisLVW403n4-YO7p6F3YSiA@jntp>
JNTP-Route: news2.nemoweb.net
JNTP-DataType: Article
Subject: [MDPI] Re: Des technologies ni =?UTF-8?Q?s=C3=BBres=20ni=20efficaces?=
References: <uhr36g$12qs3$1@dont-email.me>
Newsgroups: fr.misc.actualite.covid19
JNTP-HashClient: XkRcbWlrbIFCuH-duVEuL_U0vcM
JNTP-ThreadID: uhr36g$12qs3$1@dont-email.me
JNTP-Uri: http://news2.nemoweb.net/?DataID=nURdbisLVW403n4-YO7p6F3YSiA@jntp
User-Agent: Nemo/0.999a
JNTP-OriginServer: news2.nemoweb.net
Date: Tue, 31 Oct 23 15:31:45 +0000
Organization: Nemoweb
JNTP-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:109.0) Gecko/20100101 Firefox/119.0
Injection-Info: news2.nemoweb.net; posting-host="48db87d9176ce6969124ceb9d6b05e62333c6c22"; logging-data="2023-10-31T15:31:45Z/8357996"; posting-account="2@news2.nemoweb.net"; mail-complaints-to="newsmaster@news2.nemoweb.net"
JNTP-ProtocolVersion: 0.21.1
JNTP-Server: PhpNemoServer/0.94.5
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-JNTP-JsonNewsGateway: 0.96
From: Duzz' <jsuis@jreste.invalid>
Bytes: 2004
Lines: 17

Le 31/10/2023 à 15:32, PaulAubrin a écrit :
>
> doi: 10.3390/biomedicines11082287

[soupir] Encore MDPI
<https://www.mdpi.com/2227-9059/11/8/2287>

Cet article fait partie du numéro spécial "Problèmes émergents liés 
au COVID-19 et aux anticorps neutralisants" :
<https://www.mdpi.com/journal/biomedicines/special_issues/042A96GXQA>

Articles publiés dans ce numéro spécial (*1* article) :
<https://www.mdpi.com/journal/biomedicines/special_issues/042A96GXQA#published>

Liste des revues prédatrices de l'éditeur MDPI :
<https://predatoryreports.org/news/f/list-of-all-mdpi-predatory-publications?blogcategory=MDPI>

=> Poubelle